Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FICB vs Periarticular Infiltration for THA Pain
NCT02658240Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Apr 2016
- Primary completion
- Nov 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoints: Postoperative Pain Score at Resting at 48 hours and Postoperative Pain Score With Movement at 48 hours. Started Apr 2016; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02658240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02658240.